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ABSTRACT
Bioactive glasses (BG) are used clinically because they can both bond to hard
tissue and release therapeutic ions that can stimulate nearby cells. Lithium has
been shown to regulate the Wnt/b-catenin cell signalling pathway, which plays
important roles in the formation and repair of bone and teeth. Lithium-releasing
BG, therefore, have the potential to locally regulate hard tissue formation;
however, their design must be tailored to induce an appropriate biological
response. Here, we optimised the release of lithium from lithium-substituted BG
by varying BG composition, particle size and concentration to minimise toxicity
and maximise upregulation of the Wnt target gene Axin2 in in vitro cell cultures.
Our results show that we can tailor lithium release from BG over a wide ther-
apeutic and non-toxic range. Increasing the concentration of BG in cell culture
medium can induce toxicity, likely due to modulations in pH. Nevertheless, at
sub-toxic concentrations, lithium released from BG can upregulate the Wnt
pathway in 17IA4 cells, similarly to treatment with LiCl. Taken together, these
data demonstrate that ion release from lithium-substituted BG can be tailored to
maximise biological response. These data may be important in the design of BG
that can regulate the Wnt/b-catenin pathway to promote hard tissue repair or
regeneration.
Introduction
Bioactive glasses (BG) have been used clinically in
bone and dental restorations for more than 30 years
[1, 2]. In addition to their well-described surface
reactive properties, which allow them to directly
bond to biological tissues, BG also dissolve in the
presence of biological fluids, releasing ions that affect
nearby cells. We and others have previously shown
that ions released from BG can alter cell response in
both targeted and global contexts [3–6]. For example,
incorporating fluoride into BG upregulates markers
of bone mineralisation in human osteogenic cell cul-
tures [7], and cobalt-containing BG mimic hypoxia by
stabilising hypoxia inducible factor-1a [8]. Similarly,
modifying BG with strontium promotes an anabolic
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effect on osteoblasts and an anti-catabolic effect on
osteoclasts [9, 10], and surprisingly, strongly regu-
lates the isoprenoid pathway in human mesenchymal
stem cells [11]. BG can also be incorporated into other
biomaterials, such as glass ionomer-type [12, 13] and
other bone cements [14], which will likewise release
BG ions over time [12].
Ion release from BG is governed by a number of
factors including characteristics of the BG, such as its
composition, average particle size and concentration
in solution, as well as characteristics of the dissolu-
tion solution, including its pH and ionic composition.
Moreover, the entire process is time dependent, as
degradation of the BG structure is countered by the
precipitation of mineral (usually hydroxyapatite) on
its surface and dynamic changes in pH. Under-
standing the interplay of these factors is important in
BG design as excessive dissolution can result in tox-
icity due to the ions themselves [15] or variations in
local pH [6].
Lithium has been used clinically to treat psychiatric
patients for decades. However, in addition to its
effects on mood stabilisation, lithium also inhibits
glycogen synthase kinase-3b (GSK-3b), which
upregulates canonical Wnt/b-catenin cell signalling
[16]. As Wnt signalling plays important roles in
mineralised tissue formation [17, 18], it is not sur-
prising that lithium treatment has been shown to
enhance bone formation via this pathway in mice
[19]. And, in accordance with these observations,
patients on long-term lithium therapy show
enhanced bone mineral density [20]. Moreover,
lithium also appears to affect the formation of dental
tissues. Lithium chloride topically applied to the
dental pulp promotes dentine regeneration [21] and
administered to neural crest cells in vitro induces
odontoblast differentiation by activating Wnt sig-
nalling [22]. Lithium can be incorporated into BG by
replacing the alkali sodium ion with lithium, which
in addition to potentially providing a local thera-
peutic effect via regulation of Wnt signalling, also
reduces the BG’s crystallisation tendency, making it
more amenable to scaffold preparation [23, 24]. These
BG show reduced ion release and slightly delayed
apatite formation in vitro compared to BG without
lithium, but apatite formation is not dramatically
reduced [23, 24]. Miguez-Pacheco et al. [25] showed
that lithium-containing BG can release therapeutic
levels of lithium ions, and Khorami et al. [26]
demonstrated that they stimulate rat calvarial
osteoblast proliferation and alkaline phosphatase
activity in a dose-dependent manner.
The concentration of lithium in the serum of
patients treated with lithium has been reported in the
range 0.8 mM (5.5 ppm) [20], and so this level has
been suggested to be in the therapeutic range for
targeting bone formation via activation of the Wnt
pathway. However, in vitro studies suggest 20 mM
LiCl (139 ppm) is necessary to regulate the Wnt
pathway in mouse calvarial osteoblasts [19]. When
released from lithium-substituted BG, 17 ppm
lithium has been reported to promote the cemento-
genic differentiation of periodontal ligament cells via
activation of the Wnt pathway [27]. Nevertheless, the
appropriate concentration of lithium necessary to be
released from a BG to stimulate Wnt signalling and
promote mineralised tissue formation is still contro-
versial. Here, we aimed to systematically explore
how to tailor the ionic release of lithium from
lithium-substituted BG and lithium-substituted BG-
doped GIC to ensure their biocompatibility and
maximise their effect on mineralised tissue formation
via Wnt pathway activation.
Materials and methods
BG synthesis
SiO2–P2O5–CaO–Na2O–Li2O BG were formed using a
melt quench route, as previously described [23].
Briefly, varying amounts of Li2O were substituted for
Na2O on a molar basis (Table 1) such that BG struc-
ture (i.e. silicate network polymerisation) did not
change with the incorporation of lithium. The com-
ponents were melted in a platinum crucible at
1250 C for 1 h, then at 1350 C for 1 h and rapidly
quenched in water to obtain glass frit. BG frit were
crushed in a steel mortar and sieved to particle sizes
of either 0.1–1.0 mm (large) or \38 lm (small), to
vary relative BG surface area.
Table 1 Glass compositions (mol %)
SiO2 P2O2 CaO Na2O Li2O
Li0 (45S5) 46.1 2.6 26.9 24.4 –
Li100 46.1 2.6 26.9 – 24.4
Li75 46.1 2.6 26.9 6.1 18.3
Li50 46.1 2.6 26.9 12.2 12.2
Li25 46.1 2.6 26.9 18.3 6.1
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Formation of glass ionomer cements (GIC)
GIC modified with lithium-substituted BG were
formed by replacing part of the powder phase of
KetacTM Cem radiopaque (3M) GIC with\38 lm BG
particles (small). To maintain a constant molar
amount across the different BG compositions and to
account for differences in the atomic weights of
lithium and sodium, the mass of substituted BG was
adjusted according to Table 2. GIC were mixed
according to the manufacturer’s instructions using
50 lL of liquid per 315 mg of powder. Once thor-
oughly mixed, the cement was placed in pre-ster-
ilised moulds measuring 6 mm in diameter and
6 mm in height and placed at 37 C for 1 h to set.
Cell culture
The mouse osteoblast cell line MC3T3-E1 was
obtained from the European Collection of Cell Cul-
tures (Salisbury, UK) and cultured under standard
conditions (37 C, 5% CO2/95% air, 100% humidity)
in alpha minimum essential medium (aMEM) sup-
plemented with 10% (v/v) foetal bovine serum (FBS)
and 2 mM L-glutamine (all from Life Technologies,
Paisley, UK). The mouse dental pulp cell line 17IA4
[28] was cultured under standard conditions in
aMEM supplemented with 10% (v/v) FBS and 2 mM
L-glutamine (all from Life Technologies, Paisley, UK).
Preparation of BG-conditioned cell culture
medium
To create the initial conditioned medium (referred to
as 19), 6 mg of large BG particles per mL aMEM was
placed in 50 mL centrifuge tubes and placed onto a
laboratory tube roller at 37 C. After the specified
time period, BG particles were removed with a 0.22-
lm syringe filter and the media were stored at 4 C
prior to use. 109 medium and 509 medium were
created similarly except the concentration of BG in
the media was increased to 60 mg/mL and 300 mg/
mL, respectively. Small BG particles at equivalent
mass to volume ratios were used to make condi-
tioned medium when specified. Measurements of cell
culture medium pH were made using a standard pH
metre.
ISO10993:5 cytotoxicity testing
Cytotoxicity testing of BG-conditioned cell culture
medium and GIC was carried out according to a
modified version of ISO10993:5, as previously
described [11]. Organotin-stabilised polyvinyl chlo-
ride (PVC) sheet and non-toxic (Med7536 noDop)
tubing (both kindly provided by Raumedic AG,
Helmbrechts, Germany) were used as positive and
negative controls, respectively. Briefly, to create
control medium, materials were sterilised with 70%
ethanol for 1 h, washed with phosphate buffered
saline (PBS) and then soaked in aMEM at a surface
area to volume ratio of 3 cm2/mL for 7 days at 37 C.
GIC-conditioned medium was created identically
with the omission of the sterilisation step (as cements
were formed under sterile conditions). Conditioned
media were used neat or diluted 1:1 with fresh
aMEM (not soaked with BG) when noted. Standards
were also created by adding LiCl (Sigma) to cell
culture media. MC3T3-E1 were plated in 96-well
plates at 20000 cells/cm2 and allowed to attach for
24 h. Standard culture medium was then replaced
with LiCl-containing, conditioned or control media
supplemented with 10% FBS and 2 mM L-glutamine
for 24 h. To determine cell metabolic activity, 20 lL of
a 5 mg/ml solution of MTT [3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide; Sigma-Aldrich,
Dorset, UK] in PBS was added to each well and
returned to the incubator for 4 h. The resulting for-
mazan product was dissolved in 200 lL of dimethyl
sulfoxide (Sigma-Aldrich, Dorset, UK), and the
absorbance of the product was measured on a col-
orimetric plate reader (Thermo Multiskan Ascent 354
microplate reader) at 540 nm.
Table 2 Amount of BG and
GIC powder (in g; accounting
for differences in atomic
weights of sodium and
lithium) incorporated into
KetacTM Cem Radiopaque to
create lithium-releasing GIC
Molar equivalent to 1 g 45S5 (g) KetacTM Cem Radiopaque (g)





8834 J Mater Sci (2017) 52:8832–8844
Gene expression analyses
17IA4 were plated in 12-well plates at 25000 cells/cm2
and allowed to attach for 24 h. Standard culture
medium was then replaced with conditioned or con-
trolmedium supplementedwith 10%FBS and 2 mML-
glutamine for 24 h. Cells were detached with trypsin,
and pellets were kept at -20 C. Total RNA was
extracted from cell pellets using as RNeasy Mini Kit
(Promega) as recommended by the manufacturer. The
RNAwas reversed transcribed using random primers
(M-MLV Reverse Transcriptase kit, Promega) accord-
ing to the manufacturer’s instructions. Gene expres-
sion was then assayed by real-time PCR using Kapa
Syber Fast (KapaBiosystems) on aRotor-GeneQ cycler
(Qiagen) system. Beta-actin primers (forward—GG
CTGTATTCCCCTCCATCG, reverse—CCAGTTGG-
TAACAATGCCTGT) were used for the housekeeping
gene, and Axin2 primers (forward—TGACTCTCCT
TCCAGATCCCA, reverse—TGCCCACACTAGGCT
GACA) were used for the read-out of Wnt/b-catenin
activity. Reactions were performed in triplicate, and
relative changes to housekeeping genewere calculated
by the DDCT method.
Elemental analysis by inductively coupled
plasma mass spectroscopy (ICP–MS)
ICP–MS was carried to assess the concentration of
calcium, lithium, phosphorus and silicon ions in cell
culture media. Solutions were diluted 1:100 in 1%
nitric acid and analysed on a Perkin Elmer NexION
350D with a CETAC AX520 autosampler, using cus-
tomary calibration standards. Data were analysed
using Syngistix software.
Statistical analyses
All data are presented as means ? standard devia-
tion and represent data from at least three indepen-
dent experiments. Statistical analyses were carried
out using one-way analysis of variance followed by
post hoc Tukey test. Differences were considered
significant if p\ 0.05.
Results and discussion
We first examined the ionic composition of cell cul-
ture medium after soaking with large (0.1–1 mm) BG
particles at the 19 concentration (6 mg/mL) for 24 h
(Fig. 1a–d). The concentration of calcium in cell cul-
ture medium was similar to that in controls not
soaked with BG particles; whilst that of phosphorus
was significantly lower in the Li25, Li50, Li75 and
Li100 groups compared to controls. The concentra-
tion of silicon in culture media varied based on BG
composition, with Li25, Li50 and Li100 groups con-
taining significantly higher concentrations than con-
trols. The concentration of lithium in cell culture
media increased with increasing substitution of
lithium into the BG, and the differences in the Li75
and Li100 groups were significantly different from
that of 45S5/Li0 controls. The metabolic activities of
MC3T3-E1 cells treated with dissolution media were
all similar to that of the negative control and were
significantly different than that of the positive (cyto-
toxic) control (Fig. 1e), confirming their lack of
toxicity.
Todetermine the effect of time on ion release into cell
culture medium, we extended the incubation time up
to 7 days (Fig. 1f–i). Whilst calcium and phosphorus
concentrations decreased and silicon increased, with
time in all groups, ICP–MS analysis confirmed that the
concentration of lithium in the medium of all groups
soaked with lithium-containing BG increased with
time and continued to be governed by the amount of
lithium substituted into the BG.
Ion release patterns observed here differ markedly
from those observed previously in Tris buffer solu-
tion [24], in which ion release occurs more quickly.
That is, in Tris buffer 60% of lithium ions are released
within the first 24 h [24, 29]. Ions such as calcium,
sodium and lithium are released from BG in
exchange for protons (H? ions) from the immersion
medium [6], and previous studies have shown
marked differences in ion release and calcium phos-
phate surface layer formation from BG immersed in
Tris buffer [30] compared to that in simulated body
fluid [31] and cell culture medium [7]. Whilst cell
culture medium contains relatively high concentra-
tions of calcium and sodium (similar to SBF, which is
close to saturation in regard to apatite [32]), Tris
buffer does not, which may account for these differ-
ences. We also examined ion release in culture
medium prior to adding serum. The presence of
proteins has been shown to affect ion release from,
and apatite formation on BG [33, 34], but should not
have played a role here.
To determine the effect of the concentration of BG
particles in the solution, we next examined ion
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Figure 1 Ionic concentration of a calcium, b phosphorus, c silicon
and d lithium in cell culture media after 24-h soaking with 6 mg/
mL (19) large BG particles. e Normalised metabolic activity of
MC3T3-E1 cells after 24-h treatment with 19 (large particles) BG
dissolution medium. Ionic concentration of f calcium, g phospho-
rus, h silicon and i lithium in cell culture media after 7-day
soaking with 6 mg/mL (19) large BG particles. *p\ 0.05;
***p\ 0.001.
8836 J Mater Sci (2017) 52:8832–8844
release after increasing the mass of BG in the same
volume of medium by factors of 10 and 50. After 24 h,
the concentration of calcium in the medium of all
groups (except Li75) was significantly lower in the
109 and 509 groups compared to the 19 groups
(Fig. 2a). Similarly, the concentration of phosphorus
in the medium was significantly lower with increas-
ing concentration of BG particles (Fig. 2b). This result
seems counterintuitive as one would expect higher
concentrations of BG to result in increased ion
release. And indeed, the release of lithium from all
BG followed the expected trend of increased lithium
release with increasing concentration of BG particles.
However, as both calcium and phosphate are key
components of apatite, a mineral phase in which BG
are known to form on their surface when in contact
with physiological solutions [35], and as calcium and
phosphorus depletion is observed commonly during
apatite formation of BG [36], this observation sug-
gests that apatite formation was enhanced with
increasing BG concentration, resulting in faster cal-
cium and phosphorus depletion from the culture
medium. Lithium, by contrast, is a typical glass
modifier [6], and therefore is easily released from BG
by ion exchange. Upon release, it is incorporated into
apatite in small amounts only [37], if at all, and
concentrations in solution therefore depend on
release from the BG and are not affected by precipi-
tation reactions. Indeed, lithium concentrations in
solution seem to depend on factors including sub-
stitution in the BG, BG concentration in solution as
well as immersion medium composition.
The release of silicon showed a more complex
trend. Whilst increasing the concentration of BG
particles increased medium silicon concentrations in
all groups (except Li75, Fig. 2c), BG composition also
had an effect with a trend for decreasing silicon
release with increasing substitution of lithium for
sodium in the BG (509 only). This trend likely arises
from the effect lithium for sodium substitution has on
the BG silicate network. As lithium has a smaller
ionic radius than sodium, BG dissolution is reduced
[24], which will diminish the expected increase in
solution pH. Therefore, as both alkaline hydrolysis of
the silicate network and the solubility limit of silicon
species in aqueous solution are known to be highly
pH dependent [24], the release of silicon is likely
similarly reduced. It is well documented that silicon
ions affect cell response, particularly within the
osteogenic lineage [38]. Therefore, as its ion concen-
tration in solution changes concomitant with changes
in lithium and calcium ion concentrations, it is diffi-
cult to definitively attribute changes in cell response
to the presence of one ion or another.
Figure 1 continued.
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Figure 2 Ionic concentration of a calcium, b phosphorus, c silicon
and d lithium in cell culture media after 24-h soaking with 6 mg/
mL (19), 60 mg/mL (109) or 300 mg/mL (509) large BG
particles. e Normalised metabolic activity of MC3T3-E1 cells after
24-h treatment with 109 (large particles) BG dissolution medium.
f Normalised metabolic activity after 24-h treatment with 509
(large particles) BG dissolution medium. Ionic concentration of
g calcium, h phosphorus, i silicon and j lithium in cell culture
media after 7-day soaking with 60 mg/mL (109) small BG
particles. *p\ 0.05; **p\ 0.01; ***p\ 0.001; ****p\ 0.0001.
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To determine the toxicity of the dissolution media
after increasing BG concentration, we again mea-
sured cell metabolic activity according to ISO10993:5
tests. The normalised MTT activities of cells treated
with 109 media were all significantly higher than
that of positive controls (Fig. 2e), and none were
significantly lower than that of negative controls,
confirming their lack of toxicity. Cells treated with
509 BG, however, showed significantly lower meta-
bolic activity than negative controls, suggesting these
compositions at these concentrations were toxic to
cells (Fig. 2f).
To determine the effect of increasing BG surface
area on ion release, we next created smaller particles
(\38 lm) and analysed ion release at the 109 con-
centration over 7 days. Similar to trends with larger
BG particles, we observed decreases in the concen-
trations of calcium and phosphorus in the media with
decreasing average particle size (i.e. increasing rela-
tive surface area) compared to controls (Fig. 2g, h).
This, again, is likely attributable to faster ion release
and subsequent faster apatite formation with
increasing surface area. Similarly, the concentration
of silicon increased with time in all groups (Fig. 2i)
and the levels of lithium followed expected trends
with increases in time and with increasing lithium
content in the BG (Fig. 2j). Nevertheless, the overall
concentrations of lithium were in the range of one
order of magnitude higher compared to that achieved
with larger particles.
Ion release patterns for smaller particles resemble
more closely those observed in previous studies in
Tris buffer [24], with fast increases in ion concentra-
tions over the first 12 h, followed by relatively con-
stant concentrations over the remaining time of the
experiment. As previous studies were also performed
using small (\38 lm) BG particles, and as ions are
released in an exchange mechanism at the BG sur-
face, this suggests a strong role for the surface area to
volume ratio in addition to that of immersion med-
ium composition in affecting ion release. In short, in
in vitro studies, BG particle size as well as culture
medium composition needs to be accounted for when
evaluating ion release.
As toxicity of dissolution medium was high in cells
treated with 509 medium, which in some cases
released relative high amounts of lithium compared
to 19 and 109 groups, we hypothesised that toxicity
may have been mediated by the presence of lithium
ions. To test this, we measured the metabolic activity
Figure 2 continued.
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of cells exposed to increasing concentrations of LiCl
(Fig. 3a). Metabolic activity of cells exposed to LiCl
was significantly different from that of positive con-
trols at concentrations up to 100 mM. At higher
concentrations, toxicity was evident as metabolic
activity was significantly different to that of negative
controls and similar to that of cells treated with
medium from toxic positive control materials.
As lithium itself was not toxic at concentrations
more than an order of magnitude higher than those
detected in dissolution medium, we next hypothe-
sised that toxicity was mediated by changes in solu-
tion pH. We measured the pH of dissolution medium
formed with 19, 109 and 509 concentrations of BG
(large particles) and found that the pH of 509
lithium-containing BG treated media was signifi-
cantly higher than that of 19 controls (Fig. 3b).
Although cell culture medium is buffered, previous
reports have similarly shown that BG can cause a
cytotoxic rise in pH [39]. Mechanistically this arises as
a surplus of hydroxyl (OH-) groups is formed from
the ion exchange between modifier cations (such as
calcium, sodium or lithium ions) from the BG and
protons from the solution. Diluting these media 1:1
with fresh cell culture media resulted in significant
increases in cell metabolic activities that were similar
to those of negative controls (Fig. 3c), lending further
support to our pH hypothesis.
We next asked whether we could tailor GIC to also
release therapeutic levels of lithium. To achieve this,
we substituted some of the powder phase of a com-
mercial GIC with lithium-substituted BG. All BG
compositions allowed for the formation of stable ce-
ments, confirming that the substitution did not have a
dramatic effect on mixing, setting or mechanical sta-
bility (as determined by visual observation). To
determine ion release, we soaked the cements in cell
culture media according to ISO10993:5 and measured
ion release by ICP–MS (Fig. 4a–d). Calcium and
phosphorus levels in the media were significantly
lower in GIC-treated groups compared to standard
culture medium, and the concentration of silicon was
significantly higher. Lithium release from the GIC
followed expected trends with significant increases in
lithium in the medium with increasing concentra-
tions of lithium in the BG. Lithium-releasing GIC
have the potential to be used in applications such as
tooth regeneration and/or maintenance, in which
Wnt/b-catenin signalling plays an important role
[40].
Figure 3 a Normalised metabolic activity of MC3T3-E1 cells
after treatment with increasing concentrations of LiCl. b pH of cell
culture media after soaking for 24 h with 19, 109 and 509
concentrations of large BG particles. c Normalised metabolic
activity of MC3T3-E1 cells after 24-h treatment with 509 large
particles neat and diluted 1:1 with fresh cell culture medium.
*p\ 0.05; ***p\ 0.001; ****p\ 0.0001.
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Figure 4 Concentration of a calcium, b phosphorus, c silicon and
d lithium in cell culture medium after soaking for 7 days with BG-
modiﬁed GIC according to ISO10993:5. e Fold change in
expression of Axin2 relative to vehicle controls in 17IA4 cells
after 24-h treatment with varying concentrations of LiCl. f Fold
change in expression of Axin2 relative to vehicle controls in
17IA4 cells after 24-h treatment with 19 large BG particles soaked
in culture medium for 24 h. *p\ 0.05; **p\ 0.01;
***p\ 0.001; ****p\ 0.0001.
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Having demonstrated our ability to tailor lithium
release from the BG and GIC over a broad, sub-toxic
range via lithium substitution in the BG, we next
asked what level of lithium would need to be
released to target a biological response, specifically
activation of the Wnt/b-catenin pathway. The con-
centration of lithium in the serum of patients on
lithium maintenance therapy has been reported to be
0.8 mmol/L (5.5 ppm) [20], so this range has been
suggested to be therapeutic. However, other studies
have suggested that much higher levels (e.g. 20 mM,
139 ppm) are necessary to upregulate the Wnt path-
way [19]. To determine levels necessary to induce a
biological response, we exposed 17IA4 mouse dental
pulp cells to increasing (but sub-toxic) concentrations
of LiCl and carried out quantitative analysis of
expression of the gene Axin2, which plays important
roles in the regulation of b-catenin in the Wnt path-
way. We observed a dose-dependent increase in Ax-
in2 expression with increasing LiCl concentrations
between 10 and 50 mM (Fig. 4e). Treatment of 17IA4
cells with 100 mM LiCl (694 ppm) stimulated an
approximately 15-fold increase in expression com-
pared to vehicle controls. To confirm that similar
responses could be elicited by lithium released from
BG, we treated 17IA4 cells with 19media (24 h, large
particles), which contains concentrations of lithium
as reported in Fig. 1d. We observed significantly
higher expression of Axin2 in cells treated with Li100
compared to 45S5/Li0 and all other groups (Fig. 4f).
Conclusions
Here we show that we can tailor the release of
lithium from BG over a broad range by adjusting BG
composition, concentration in cell culture medium
and particle size. The resulting dissolution medium
is non-toxic for many of the combinations of
parameters we tested and can elicit an effect on
Wnt/b-catenin signalling that mirrors that induced
by treating cells with LiCl. High concentrations of
BG in cell culture media can induce a cytotoxic
response that is likely mediated by changes in
solution pH, but this can be ameliorated by diluting
dissolution medium with fresh medium or using a
lower concentration of the BG. These studies may be
important in the design of non-toxic lithium-releas-
ing materials that can modulate the Wnt pathway
for hard tissue regeneration.
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